-
Kako najhitreje odpraviti simptome in pozdraviti ezofagitis? = How to relieve the symptoms and to cure esophagitis effectivelly?Ivanuša, Marijan, 1966-The incidence of gastroesophageal reflux disease (GERD) continues to rise in the western part of the world, hand in hand with an increasing incidence of esophageal cancer. However, despite the high ... incidence of the condition, patients rarely seek medical attention. Esophagitis, the most common sequel ofgastroesophageal reflux, has an annual incidence of 1% and a prevalence of 5%. Although we understand the pathophysiological mechanisms of GERD, the etiology of the idiopathic type of the disease has not yet been clarified. Themost common and characteristic symptom of GERD is heartburn. Another commonly experienced symptom is sour or bitter regurgitation. ln addition, GERD symptomatology may include atypical symptoms (caugh, hoarseness, retrosternal pain). Endoscopy may reveal mucosal abnormalities. In the absenceof endoscopic evidence of mucosal abnormalities we speak of an endoscopically negative GERD. ln this case evidence of GERD can be obtained by24-hour pH-metry, manometry and bile reflux measurement, but these tests areto rarely performed. ln patients presenting with a typical clinical pictureof GERD, treatment is started without performing the above tests. Acutetreatment is usually started with a proton pump inhibitor (omeprazole, pantoprazole, lansoprazole, rabeprazole) and continued with maintenance therapy using the drug that still maintains remission. Today, omeprazofe is increasingly used for long-term maintenance treatment as well. lt is a standard proton pump inhibitor. Newer proton pump inhibitors do not have important advantages for the patients. Some clinical trials have shown, that lansoprazole can faster relieve the symptoms.Vir: Medicinsko-tehnični pripomočki : zbornik (Str. 69-74)Vrsta gradiva - prispevek na konferenciLeto - 2004Jezik - slovenskiCOBISS.SI-ID - 18927321
Avtor
Ivanuša, Marijan, 1966-
Teme
Gastroesophageal Reflux |
Physiopathology |
Diagnosis |
Drug Therapy |
Esophagitis, Peptic |
Anti-Ulcer Agents |
Heartburn |
Endoscopy, Gastrointestinal |
Proton Pump |
Antagonists And Inhibitors |
Antacids |
Histamine H2 Antagonists |
Ezofagitis peptični |
Gastroezofagealni refluks |
Protiulkusna zdravila |
Antacidi |
Endoskopija gastrointestinalna |
Histamin, H2 antagonisti |
Protonska črpalka |
Zgaga
![loading ... loading ...](themes/default/img/ajax-loading.gif)
Vnos na polico
Trajna povezava
- URL:
Faktor vpliva
Dostop do baze podatkov JCR je dovoljen samo uporabnikom iz Slovenije. Vaš trenutni IP-naslov ni na seznamu dovoljenih za dostop, zato je potrebna avtentikacija z ustreznim računom AAI.
Leto | Faktor vpliva | Izdaja | Kategorija | Razvrstitev | ||||
---|---|---|---|---|---|---|---|---|
JCR | SNIP | JCR | SNIP | JCR | SNIP | JCR | SNIP |
Baze podatkov, v katerih je revija indeksirana
Ime baze podatkov | Področje | Leto |
---|
Povezave do osebnih bibliografij avtorjev | Povezave do podatkov o raziskovalcih v sistemu SICRIS |
---|---|
Ivanuša, Marijan, 1966- | ![]() |
Izberite prevzemno mesto:
Prevzem gradiva po pošti
Obvestilo
Gesla v Splošnem geslovniku COBISS
Izbira mesta prevzema
Mesto prevzema | Status gradiva | Rezervacija |
---|
Prosimo, počakajte trenutek.